FI20030958A0 - Nya föreningar - Google Patents

Nya föreningar

Info

Publication number
FI20030958A0
FI20030958A0 FI20030958A FI20030958A FI20030958A0 FI 20030958 A0 FI20030958 A0 FI 20030958A0 FI 20030958 A FI20030958 A FI 20030958A FI 20030958 A FI20030958 A FI 20030958A FI 20030958 A0 FI20030958 A0 FI 20030958A0
Authority
FI
Finland
Prior art keywords
compounds
formula
new compounds
andropause
sarm
Prior art date
Application number
FI20030958A
Other languages
English (en)
Finnish (fi)
Inventor
Jari Ratilainen
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Priority to FI20030958A priority Critical patent/FI20030958A0/sv
Publication of FI20030958A0 publication Critical patent/FI20030958A0/sv
Priority to TW093117617A priority patent/TWI336321B/zh
Priority to EP04742130A priority patent/EP1641745B1/en
Priority to MXPA05013619A priority patent/MXPA05013619A/es
Priority to PT04742130T priority patent/PT1641745E/pt
Priority to KR1020057024544A priority patent/KR20060035629A/ko
Priority to BRPI0411939-8A priority patent/BRPI0411939A/pt
Priority to ES04742130T priority patent/ES2343251T3/es
Priority to YU20050957A priority patent/RS52816B/sr
Priority to DE602004026583T priority patent/DE602004026583D1/de
Priority to PL04742130T priority patent/PL1641745T3/pl
Priority to US10/561,231 priority patent/US7390923B2/en
Priority to AU2004251900A priority patent/AU2004251900B2/en
Priority to SI200431436T priority patent/SI1641745T1/sl
Priority to JP2006516233A priority patent/JP4809764B2/ja
Priority to MEP-2008-865A priority patent/ME00522B/me
Priority to CA2529464A priority patent/CA2529464C/en
Priority to UAA200600713A priority patent/UA86027C2/ru
Priority to DK04742130.0T priority patent/DK1641745T3/da
Priority to NZ543974A priority patent/NZ543974A/en
Priority to AT04742130T priority patent/ATE464284T1/de
Priority to EA200600110A priority patent/EA012430B1/ru
Priority to CL200401602A priority patent/CL2004001602A1/es
Priority to PCT/FI2004/000387 priority patent/WO2005000794A1/en
Priority to ARP040102263A priority patent/AR044934A1/es
Priority to IL172279A priority patent/IL172279A0/en
Priority to NO20060227A priority patent/NO332252B1/no
Priority to IS8256A priority patent/IS2752B/is
Priority to HRP20060036AA priority patent/HRP20060036B1/hr
Priority to HK07100331.1A priority patent/HK1093964A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/68—One oxygen atom attached in position 4
FI20030958A 2003-06-27 2003-06-27 Nya föreningar FI20030958A0 (sv)

Priority Applications (30)

Application Number Priority Date Filing Date Title
FI20030958A FI20030958A0 (sv) 2003-06-27 2003-06-27 Nya föreningar
TW093117617A TWI336321B (en) 2003-06-27 2004-06-18 Propionamide derivatives useful as androgen receptor modulators
PCT/FI2004/000387 WO2005000794A1 (en) 2003-06-27 2004-06-24 Propionamide derivatives useful as androgen receptor modulators
JP2006516233A JP4809764B2 (ja) 2003-06-27 2004-06-24 アンドロゲン受容体モジュレーターとして有用なプロピオンアミド誘導体
MEP-2008-865A ME00522B (me) 2003-06-27 2004-06-24 Derivati propionamida koji se koriste kao modulatori androgenih receptora
PT04742130T PT1641745E (pt) 2003-06-27 2004-06-24 Derivados de propionamida úteis como moduladores do receptor de androgénio
KR1020057024544A KR20060035629A (ko) 2003-06-27 2004-06-24 안드로젠 수용체 모듈레이터로 유용한 프로피온아마이드유도체들
BRPI0411939-8A BRPI0411939A (pt) 2003-06-27 2004-06-24 derivados de propionamida úteis como moduladores de receptores de androgênio
ES04742130T ES2343251T3 (es) 2003-06-27 2004-06-24 Derivados de propionamida utiles como moduladores del receptor de androgenos.
YU20050957A RS52816B (sr) 2003-06-27 2004-06-24 Derivati propionamida koji se koriste kao modulatori androgenih receptora
DE602004026583T DE602004026583D1 (de) 2003-06-27 2004-06-24 Als androgenrezeptormodulatoren geeignete propionamidderivate
PL04742130T PL1641745T3 (pl) 2003-06-27 2004-06-24 Pochodne propionoamidowe użyteczne jako modulatory receptora androgenowego
US10/561,231 US7390923B2 (en) 2003-06-27 2004-06-24 Propionamide derivatives useful as androgen receptor modulators
AU2004251900A AU2004251900B2 (en) 2003-06-27 2004-06-24 Propionamide derivatives useful as androgen receptor modulators
SI200431436T SI1641745T1 (sl) 2003-06-27 2004-06-24 Propionamidni derivati, uporabni kot modulatorji androgenskega receptorja
EP04742130A EP1641745B1 (en) 2003-06-27 2004-06-24 Propionamide derivatives useful as androgen receptor modulators
MXPA05013619A MXPA05013619A (es) 2003-06-27 2004-06-24 Nuevos compuestos.
CA2529464A CA2529464C (en) 2003-06-27 2004-06-24 Propionamide derivatives useful as androgen receptor modulators
UAA200600713A UA86027C2 (ru) 2003-06-27 2004-06-24 Производные пропионамида, полезные как модуляторы андрогенных рецепторов
DK04742130.0T DK1641745T3 (da) 2003-06-27 2004-06-24 Propionamidderivater nyttige som androgenreceptormodulatorer
NZ543974A NZ543974A (en) 2003-06-27 2004-06-24 Propionamide derivatives useful as androgen receptor modulators
AT04742130T ATE464284T1 (de) 2003-06-27 2004-06-24 Als androgenrezeptormodulatoren geeignete propionamidderivate
EA200600110A EA012430B1 (ru) 2003-06-27 2004-06-24 Производные пропионамида, полезные в качестве модуляторов андрогенных рецепторов
CL200401602A CL2004001602A1 (es) 2003-06-27 2004-06-24 Compuestos no esteroidales derivados de propionanilida, moduladores del receptor androgenico con selectividad tisular (sarm); composicion farmaceutica; y uso en el tratamiento o prevencion de condiciones dependientes del receptor androgenico, como hi
ARP040102263A AR044934A1 (es) 2003-06-27 2004-06-25 Derivados de propioanilidas, su uso como moduladores de receptores de androgenos. composiciones farmaceuticas.
IL172279A IL172279A0 (en) 2003-06-27 2005-11-30 Propionamide derivatives useful as androgen receptor modulators
NO20060227A NO332252B1 (no) 2003-06-27 2006-01-16 Propionamidderivater og farmasoytisk sammensetning anvendelig ved behandling eller forebygging av androgenmangel.
IS8256A IS2752B (is) 2003-06-27 2006-01-23 Própíónamíðafleiður@sem@eru@gagnlegar@sem@andrógenviðtakastillar
HRP20060036AA HRP20060036B1 (hr) 2003-06-27 2006-01-26 Derivati propionamida koji se koriste kao modulatori androgenih receptora
HK07100331.1A HK1093964A1 (en) 2003-06-27 2007-01-10 Propionamide derivatives useful as androgen receptor modulators

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20030958A FI20030958A0 (sv) 2003-06-27 2003-06-27 Nya föreningar

Publications (1)

Publication Number Publication Date
FI20030958A0 true FI20030958A0 (sv) 2003-06-27

Family

ID=8566309

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20030958A FI20030958A0 (sv) 2003-06-27 2003-06-27 Nya föreningar

Country Status (21)

Country Link
US (1) US7390923B2 (sv)
EP (1) EP1641745B1 (sv)
JP (1) JP4809764B2 (sv)
AT (1) ATE464284T1 (sv)
AU (1) AU2004251900B2 (sv)
BR (1) BRPI0411939A (sv)
CA (1) CA2529464C (sv)
CL (1) CL2004001602A1 (sv)
DK (1) DK1641745T3 (sv)
EA (1) EA012430B1 (sv)
ES (1) ES2343251T3 (sv)
FI (1) FI20030958A0 (sv)
ME (1) ME00522B (sv)
NZ (1) NZ543974A (sv)
PL (1) PL1641745T3 (sv)
PT (1) PT1641745E (sv)
RS (1) RS52816B (sv)
SI (1) SI1641745T1 (sv)
TW (1) TWI336321B (sv)
UA (1) UA86027C2 (sv)
WO (1) WO2005000794A1 (sv)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7205437B2 (en) * 1996-11-27 2007-04-17 University Of Tennessee Research Foundation Selective androgen receptor modulators
US7759520B2 (en) 1996-11-27 2010-07-20 University Of Tennessee Research Foundation Synthesis of selective androgen receptor modulators
US7518013B2 (en) 2000-08-24 2009-04-14 University Of Tennessee Research Foundation Selective androgen receptor modulators
US20090264534A1 (en) * 1996-11-27 2009-10-22 Dalton James T Selective androgen receptor modulators
US7645898B2 (en) 2000-08-24 2010-01-12 University Of Tennessee Research Foundation Selective androgen receptor modulators and method of use thereof
US7855229B2 (en) 2000-08-24 2010-12-21 University Of Tennessee Research Foundation Treating wasting disorders with selective androgen receptor modulators
US7622503B2 (en) 2000-08-24 2009-11-24 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US7919647B2 (en) 2000-08-24 2011-04-05 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US8445534B2 (en) 2000-08-24 2013-05-21 University Of Tennessee Research Foundation Treating androgen decline in aging male (ADAM)-associated conditions with SARMs
US8008348B2 (en) 2001-12-06 2011-08-30 University Of Tennessee Research Foundation Treating muscle wasting with selective androgen receptor modulators
US8853266B2 (en) 2001-12-06 2014-10-07 University Of Tennessee Research Foundation Selective androgen receptor modulators for treating diabetes
IL162340A0 (en) 2001-12-06 2005-11-20 Gtx Inc Treating muscle wasting with selective androgen receptor modulators
WO2004035738A2 (en) 2002-10-15 2004-04-29 University Of Tennessee Research Foundation Methylene-bridged selective androgen receptor modulators and methods of use thereof
US8309603B2 (en) 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
JP2007513998A (ja) 2003-12-16 2007-05-31 ジーティーエックス・インコーポレイテッド 選択的アンドロゲン受容体調節剤のプロドラッグ及びその使用方法
AP2006003700A0 (en) 2004-02-13 2006-08-31 Warner Lambert Co Androgen receptor modulators
WO2005100305A1 (en) * 2004-04-13 2005-10-27 Warner-Lambert Company Llc Androgen modulators
CA2562672C (en) 2004-04-22 2009-09-29 Warner-Lambert Company Llc 4-cyano-phenoxy derivatives as androgen modulators
US9884038B2 (en) 2004-06-07 2018-02-06 University Of Tennessee Research Foundation Selective androgen receptor modulator and methods of use thereof
US9889110B2 (en) 2004-06-07 2018-02-13 University Of Tennessee Research Foundation Selective androgen receptor modulator for treating hormone-related conditions
ATE552235T1 (de) * 2004-06-07 2012-04-15 Univ Tennessee Res Foundation Selektive androgen-rezeptor-modulator und anwendungsverfahren dafür
JP4874965B2 (ja) 2004-07-08 2012-02-15 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー アンドロゲン調節剤
TW200724139A (en) 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators
US8501814B2 (en) * 2006-03-03 2013-08-06 Orion Corporation Selective androgen receptor modulators
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
US10010521B2 (en) 2006-08-24 2018-07-03 University Of Tennessee Research Foundation SARMs and method of use thereof
US9730908B2 (en) 2006-08-24 2017-08-15 University Of Tennessee Research Foundation SARMs and method of use thereof
US7968603B2 (en) 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators
US8268872B2 (en) 2008-02-22 2012-09-18 Radius Health, Inc. Selective androgen receptor modulators
EP2260028B1 (en) 2008-02-22 2014-05-07 Radius Health, Inc. Selective androgen receptor modulators
MX338831B (es) 2010-02-04 2016-05-03 Radius Health Inc Moduladores selectivos de receptores de androgenos.
MX342898B (es) 2010-05-12 2016-10-18 Radius Health Inc * Regimen terapéutico de la sal de diclorhidrato del (r) -6-(2-(etil (4-2(etilamino) etil) bencil) amino)-4-metoxifenil)-5, 6,7,8-tetrahidronaftaleno-2-ol.
US8642632B2 (en) 2010-07-02 2014-02-04 Radius Health, Inc. Selective androgen receptor modulators
EP2621901B1 (en) 2010-09-28 2015-07-29 Radius Health, Inc Selective androgen receptor modulators
FR2982261B1 (fr) 2011-11-04 2014-06-13 Galderma Res & Dev Nouveaux amides, et leur utilisation pharmaceutique ou cosmetique
KR102122941B1 (ko) 2012-07-13 2020-06-15 지티엑스, 인코포레이티드 선택적 안드로겐 수용체 조절자(sarms)를 이용한 안드로겐 수용체(ar) 양성 유방암의 치료 방법
US9969683B2 (en) 2012-07-13 2018-05-15 Gtx, Inc. Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US10987334B2 (en) 2012-07-13 2021-04-27 University Of Tennessee Research Foundation Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
US10314807B2 (en) 2012-07-13 2019-06-11 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
FI3122426T3 (fi) 2014-03-28 2023-03-31 Univ Duke Rintasyövän hoitaminen käyttäen selektiivisiä estrogeenin reseptorin modulaattoreita
US9421264B2 (en) 2014-03-28 2016-08-23 Duke University Method of treating cancer using selective estrogen receptor modulators
BR112017007916A2 (pt) * 2014-10-16 2018-01-23 Gtx Inc compostos sarms para tratamento de distúrbios urológicos
US10093613B2 (en) 2015-04-21 2018-10-09 Gtx, Inc. Selective androgen receptor degrader (SARD) ligands and methods of use thereof
MX2017013565A (es) * 2015-04-21 2018-02-19 Gtx Inc Ligandos degradadores selectivos del receptor androgénico (sard) y sus métodos uso.
US10441570B2 (en) 2015-04-21 2019-10-15 University Of Tennessee Research Foundation Selective androgen receptor degrader (SARD) Ligands and methods of use thereof
US10654809B2 (en) 2016-06-10 2020-05-19 University Of Tennessee Research Foundation Selective androgen receptor degrader (SARD) ligands and methods of use thereof
US10017471B2 (en) 2015-04-21 2018-07-10 University Of Tennessee Research Foundation Selective androgen receptor degrader (SARD) ligands and methods of use thereof
US10806720B2 (en) 2015-04-21 2020-10-20 University Of Tennessee Research Foundation Selective androgen receptor degrader (SARD) ligands and methods of use thereof
US10035763B2 (en) 2015-04-21 2018-07-31 Gtx, Inc. Selective androgen receptor degrader (SARD) ligands and methods of use thereof
US9814698B2 (en) 2015-04-21 2017-11-14 University Of Tennessee Research Foundation Selective androgen receptor degrader (SARD) ligands and methods of use thereof
US10865184B2 (en) 2015-04-21 2020-12-15 University Of Tennessee Research Foundation Selective androgen receptor degrader (SARD) ligands and methods of use thereof
US9834507B2 (en) * 2015-04-21 2017-12-05 University Of Tennessee Research Foundation Selective androgen receptor degrader (SARD) ligands and methods of use thereof
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
US11230523B2 (en) 2016-06-10 2022-01-25 University Of Tennessee Research Foundation Selective androgen receptor degrader (SARD) ligands and methods of use thereof
KR102397890B1 (ko) 2016-06-22 2022-05-12 일립시스 파마 리미티드 Ar+ 유방암 치료 방법
AU2018205285C1 (en) 2017-01-05 2023-08-24 Radius Pharmaceuticals, Inc. Polymorphic forms of RAD1901-2HCl
CA3104395A1 (en) 2018-07-04 2020-01-09 Radius Pharmaceuticals, Inc. Polymorphic forms of rad1901-2hcl
WO2020051260A1 (en) * 2018-09-05 2020-03-12 University Of Tennessee Research Foundation Selective androgen receptor degrader (sard) ligands and methods of use thereof
WO2020073017A1 (en) * 2018-10-05 2020-04-09 University Of Tennesse Research Foundation Selective androgen receptor degrader (sard) ligands and methods of use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100172B1 (en) * 1982-07-23 1987-08-12 Imperial Chemical Industries Plc Amide derivatives
US6995284B2 (en) * 2000-08-24 2006-02-07 The University Of Tennessee Research Foundation Synthesis of selective androgen receptor modulators
US6838484B2 (en) * 2000-08-24 2005-01-04 University Of Tennessee Research Foundation Formulations comprising selective androgen receptor modulators
US7026500B2 (en) * 2000-08-24 2006-04-11 University Of Tennessee Research Foundation Halogenated selective androgen receptor modulators and methods of use thereof
KR20030061783A (ko) * 2000-08-24 2003-07-22 더 유니버시티 오브 테네시 리서치 코포레이션 선택적 안드로겐 수용체 조절제 및 이들의 사용 방법
IL162340A0 (en) * 2001-12-06 2005-11-20 Gtx Inc Treating muscle wasting with selective androgen receptor modulators
CN101732298B (zh) 2002-02-07 2012-09-19 田纳西大学研究基金会 用sarms治疗良性前列腺增生
EA009199B1 (ru) * 2002-06-17 2007-12-28 Юниверсити Оф Теннесси Рисерч Фаундейшн N-мостиковые селективные модуляторы андрогенных рецепторов и способы их применения
EP1558232A4 (en) * 2002-10-15 2008-07-02 Gtx Inc TREATMENT OF FAT SUPPORT WITH SELECTIVE ANDROGEN RECEPTOR MODULATORS
WO2004035739A2 (en) * 2002-10-16 2004-04-29 Gtx, Inc. Treating androgen decline in aging male (adam)-associated conditions with sarms
WO2004062612A2 (en) * 2003-01-13 2004-07-29 Gtx Inc. Large-scale synthesis of selective androgen receptor modulators
CN1771031A (zh) * 2003-01-22 2006-05-10 Gtx公司 用sarms治疗与女性雄激素缺乏(ad if)相关的疾病

Also Published As

Publication number Publication date
NZ543974A (en) 2009-04-30
WO2005000794A1 (en) 2005-01-06
EA200600110A1 (ru) 2006-06-30
SI1641745T1 (sl) 2010-07-30
PL1641745T3 (pl) 2010-09-30
RS52816B (sr) 2013-10-31
AU2004251900A1 (en) 2005-01-06
TWI336321B (en) 2011-01-21
ATE464284T1 (de) 2010-04-15
AU2004251900B2 (en) 2009-10-22
US7390923B2 (en) 2008-06-24
UA86027C2 (ru) 2009-03-25
RS20050957A (en) 2008-04-04
CA2529464A1 (en) 2005-01-06
EP1641745B1 (en) 2010-04-14
ME00522B (me) 2011-10-10
PT1641745E (pt) 2010-05-25
ES2343251T3 (es) 2010-07-27
CL2004001602A1 (es) 2005-05-20
EA012430B1 (ru) 2009-10-30
BRPI0411939A (pt) 2006-08-15
DK1641745T3 (da) 2010-07-26
JP4809764B2 (ja) 2011-11-09
TW200505419A (en) 2005-02-16
JP2007520425A (ja) 2007-07-26
EP1641745A1 (en) 2006-04-05
US20070123512A1 (en) 2007-05-31
CA2529464C (en) 2012-01-03

Similar Documents

Publication Publication Date Title
FI20030958A0 (sv) Nya föreningar
MX2007004699A (es) Derivados de indol y bencimidazol.
MY151295A (en) Pyrimidyl indoline compound
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
MX2012009186A (es) Pirrolidina-2-carboxamidas sustituidas.
RS52823B (en) NEW UNITS USEFUL FOR TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
TW200612958A (en) Substituted imidazole derivatives
WO2007117465A3 (en) Indazole compounds
MY152271A (en) Novel compounds that are erk inhibitors
WO2007084728A3 (en) 2-imino-benzimidazoles
JO3602B1 (ar) مركبات بنزيميدازول بصفتها منظمات لمستقبلات في ار 1
RS53617B1 (en) NEW UNITS USEFUL FOR TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
MX2013004162A (es) Composiciones farmaceuticas que contienen un inhibidor de dgat1.
MY153763A (en) Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof
ZA200806778B (en) N-Hydroxyacrylamide compounds
EA201071183A1 (ru) Безводная кристаллическая форма малеата орвепитанта
MX2013002620A (es) Novedosas n-hidroxi-benzamidas para el tratamiento del cancer.
MX2012004835A (es) Derivados de espirolactama y usos de los mismos.
MX2009013003A (es) Derivados de piperidina-amida.
TW200720273A (en) Pharmaceutically active spiro-benzimidazoles
MY139228A (en) Imidazolinylmethyl aralkylsulfonamides
IL206570A (en) 4,3-Dihydro Compound-1 h- Isoquinoline is converted into 3 positions, process for preparation and use
WO2006004903A3 (en) 1,2-bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof
MXPA05013619A (es) Nuevos compuestos.
TNSN08242A1 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof

Legal Events

Date Code Title Description
FD Application lapsed

Free format text: FI 6490